Society for Endocrinology - a world-leading authority on hormones

Society strategy 2024 - 2027

The Council of the Society for Endocrinology is seeking the views of members on a new strategy for the Society.

The Society for Endocrinology was formed in 1946 and exists to advance the understanding of endocrinology.  Our work centres on bringing together the endocrine community, providing support for scientists, doctors, nurses and associated professionals working in the field of hormones who are improving patient outcomes, undertaking cutting-edge research which furthers the understanding of the endocrine system, and ensuring that people can make better healthcare choices.

Now, is a critical time for the Society to set priorities for two main reasons:

  1. We are emerging from a global pandemic which has changed the way organisations and individuals work, meaning our members are facing different challenges with different expectations of us.
  2. There are challenges facing the Society’s trading subsidiary, Bioscientifica, which mean the Society’s main revenue stream is going to be reduced over the next few years.

Developing a new strategy will allow us move forward with clarity and focus and ensure the Society is delivering its mission in the most impactful way within its available resources.

Financial stability, operational efficiency and robust governance underpin the success of the Society, whatever its strategic priorities. With these in mind we know we need to meet the following objectives over the coming years.

  • Diversify and develop our revenue streams
  • Improve our membership system and processes
  • Continue to implement recommendations from our governance review 2020/1

We intend that this strategy will enable us to achieve the best impact and value for our members we possibly can offer over the coming years.

Council have prepared a draft strategy consisting of four strategic goals, and a number of objectives that the Society plans to focus on over the next four years 2024-27.

We value feedback on these goals and objectives from all members across the breadth of our Society. Please email your comments and suggestions to by Monday 12 June.

With thanks in advance,

Your Society for Endocrinology Council [display below names in 2 or 3 columns if poss]

Márta Korbonits (President)

Ruth Andrew (General Secretary)

Mark Gurnell (Treasurer)

Rob Semple (Programme Secretary)

Antonia Brooke

Shareen Forbes

Marie Freel

Tara Kearney

Miles Levy

Onyebuchi Okosieme

Michael O’Reilly

Helen Simpson

Kristien Boelaert (Chair of Clinical Committee)

Channa Jayasena (Chair of Public Engagement Committee)

Louise Breen (Chair of Nurse Committee)

Kevin Murphy (Chair of Science Committee)

Jeremy Turner (Chair of Corporate Liaison Committee)

Mark Turner (Chair of Early Career Committee)